Geographical variation in Plasmodium vivax relapse

被引:206
作者
Battle, Katherine E. [1 ]
Karhunen, Markku S. [1 ]
Bhatt, Samir [1 ]
Gething, Peter W. [1 ]
Howes, Rosalind E. [1 ]
Golding, Nick [1 ]
Van Boeckel, Thomas P. [2 ]
Messina, Jane P. [1 ]
Shanks, G. Dennis [3 ]
Smith, David L. [4 ,5 ,6 ]
Baird, J. Kevin [7 ,8 ]
Hay, Simon I. [1 ,6 ]
机构
[1] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England
[2] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[3] Australian Army Malaria Inst, Enoggera, Qld, Australia
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA
[6] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA
[7] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia
[8] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England
基金
英国惠康基金; 美国国家卫生研究院; 比尔及梅琳达.盖茨基金会;
关键词
Malaria; Plasmodium vivax; Map; Relapse; Periodicity; Recurrence; Recrudescence; Strain; PRIMAQUINE REGIMENS; FALCIPARUM-MALARIA; RISK-FACTORS; CHLOROQUINE; PAPUA; PREVENTION; THERAPY; BURDEN; EPIDEMIOLOGY; TRANSMISSION;
D O I
10.1186/1475-2875-13-144
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Plasmodium vivax has the widest geographic distribution of the human malaria parasites and nearly 2.5 billion people live at risk of infection. The control of P. vivax in individuals and populations is complicated by its ability to relapse weeks to months after initial infection. Strains of P. vivax from different geographical areas are thought to exhibit varied relapse timings. In tropical regions strains relapse quickly (three to six weeks), whereas those in temperate regions do so more slowly (six to twelve months), but no comprehensive assessment of evidence has been conducted. Here observed patterns of relapse periodicity are used to generate predictions of relapse incidence within geographic regions representative of varying parasite transmission. Methods: A global review of reports of P. vivax relapse in patients not treated with a radical cure was conducted. Records of time to first P. vivax relapse were positioned by geographic origin relative to expert opinion regions of relapse behaviour and epidemiological zones. Mixed-effects meta-analysis was conducted to determine which geographic classification best described the data, such that a description of the pattern of relapse periodicity within each region could be described. Model outputs of incidence and mean time to relapse were mapped to illustrate the global variation in relapse. Results: Differences in relapse periodicity were best described by a historical geographic classification system used to describe malaria transmission zones based on areas sharing zoological and ecological features. Maps of incidence and time to relapse showed high relapse frequency to be predominant in tropical regions and prolonged relapse in temperate areas. Conclusions: The results indicate that relapse periodicity varies systematically by geographic region and are categorized by nine global regions characterized by similar malaria transmission dynamics. This indicates that relapse may be an adaptation evolved to exploit seasonal changes in vector survival and therefore optimize transmission. Geographic patterns in P. vivax relapse are important to clinicians treating individual infections, epidemiologists trying to infer P. vivax burden, and public health officials trying to control and eliminate the disease in human populations.
引用
收藏
页数:16
相关论文
共 91 条
[1]   Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia [J].
Alvarez, Gonzalo ;
Pineros, Juan-Gabriel ;
Tobon, Alberto ;
Rios, Alexandra ;
Maestre, Amanda ;
Blair, Silvia ;
Carmona-Fonseca, Jaime .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (04) :605-609
[2]  
[Anonymous], 2013, LANG ENV STAT COMP
[3]  
[Anonymous], 1969, A Textbook of Malaria Eradication
[4]  
[Anonymous], GUIDL TREATM MAL
[5]   The pathophysiology of vivax malaria [J].
Anstey, Nicholas M. ;
Russell, Bruce ;
Yeo, Tsin W. ;
Price, Ric N. .
TRENDS IN PARASITOLOGY, 2009, 25 (05) :220-227
[6]   The global pipeline of new medicines for the control and elimination of malaria [J].
Anthony, Melinda P. ;
Burrows, Jeremy N. ;
Duparc, Stephan ;
JMoehrle, Joerg ;
Wells, Timothy N. C. .
MALARIA JOURNAL, 2012, 11
[7]  
ARNOLD J, 1954, J LAB CLIN MED, V44, P723
[8]   Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial [J].
Awab, Ghulam Rahim ;
Pukrittayakamee, Sasithon ;
Imwong, Mallika ;
Dondorp, Arjen M. ;
Woodrow, Charles J. ;
Lee, Sue Jean ;
Day, Nicholas P. J. ;
Singhasivanon, Pratap ;
White, Nicholas J. ;
Kaker, Faizullah .
MALARIA JOURNAL, 2010, 9
[9]   Eliminating malaria-all of them [J].
Baird, J. Kevin .
LANCET, 2010, 376 (9756) :1883-1885
[10]   Chloroquine resistance in Plasmodium vivax [J].
Baird, JK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4075-4083